The Effects of Amino Acids Enriched Del Nido Cardioplegia on Myocardial Leucocyte Accumulation and Ventricular Functions in Patients Undergoing Coronary Artery Bypass Grafting Surgery

Authors

  • Zeki Temizturk, MD Department of cardiovascular Surgery, The Health Science University Elazig Research and Education Hospital, Elazig, Turkey
  • Davut Azboy, MD Department of Cardiovascular Surgery, Firat University School of Medicine, Elazig, Turkey
  • Ayhan Uysal, MD Department of Cardiovascular Surgery, Firat University School of Medicine, Elazig, Turkey

DOI:

https://doi.org/10.1532/hsf.3265

Keywords:

Myocardial impairement, leucocytes, del Nido cardioplegia, glutamate, aspartate, reperfusion injury, coronary artery by-pass grafting surgery

Abstract

Background: One of the main sources of ischemia/reperfusion injury (IRI) and release of free oxygen radicals (FORs) during extracorporeal circulation (ECC) during cardiac surgery is neutrophils. In this study, we investigated the potential effects of our modification of del Nido cardioplegia (mDNC) (amino acids enriched del Nido cardioplegia) on myocardial polymorphonuclear leucocyte (PMNL) accumulation. We also compared the effects of our mDND and classical del Nido cardiplegia (cDNC) on ventricular contractile functions in coronary artery bypass grafting (CABG) surgery.

Patients and methods: Our study included 100 isolated CABG patients with similar characteristics, including age, gender, preoperative medications, diabetes, hypertension, and left ventricular ejection fraction (LVEF). The patients were divided into two groups. Amino acids supplemented del Nido cardioplegia (L-aspartate and L-glutamate at a dose of 13 milimol/L) in 50 patients (study group, G1). In the remaining 50 patients, we used a classical del Nido cardioplegic solution (cDNC) (control group, G2). Myocardial Tru-Cut biopsy from the right ventricle was taken before the institution of ECC and after weaning from ECC in all patients. Cardiac troponine-I (cTn-I), tumor necrosis factor-alpha (TNF-Alpha), Pro-Brain Natriuretic Peptide (Pro-BNP), and lactate levels were measured pre- and postoperatively. Invasive monitoring was performed to provide the left ventricular functions in both groups in the operating room and noted by a
blinded anaesthesiologist.

Results: Five patients died post-surgery (5%) (two from SG and three from CG (P = .67), due to low cardiac output syndrome or multiorgan failure. At the postoperative period, cardiac output (CO) and stroke volume index (SVI) was higher in mDNC (mean ± SDS; 32.1 ± 7 versus 22.2 ± 6.9 mL/min/m² (P < .001). CI was significantly higher in mDNC after surgery (3.10 ± 0.76 versus 2.40 ± 0.30L/min/m²
(P = .002). Ten patients (20%) in mDNC and 16 patients (32%) in cDNC required inotropic support (P < .001). The postoperative inotropic requirement was less in mDNC (6.1 ± 1.8 mg/kg versus 9.2 ± 1.9 mg/kg, P < .004). Blood gas analyses from the coronary sinus showed that myocardial acidosis was more severe in the control group [pH (0.10 ± 0.09 versus 0.054 ± 0.001; P = .34)]. Blood lactate levels were significantly high in the control group (1.01 ± 0.007 mmol/L versus 1.92 ± 0.35 mmol/L) (P = .22). No difference was found when compared with cardioplegia volume in the mDNC and cDNC groups (mDNC= 990.00 ± 385 mL in DNC = 960 ± 240 mL, P = .070). An aortic cross-clamp time in the mDNC and cDNC groups were 88.4 ± 8.9 min, and 93 ± 11 min, (P = .76), but cardiopulmonary bypass time was significantly low in mDNC (mDNC = 98.3 ± 22.5 min, DNC = 126 ± 19.5 min, P = .0020). TNF-Alpha and Pro-BNP levels in patients received mDNC were significantly low (P = .022). Postoperative cardiac enzyme levels (creatine kinase-MB and high sensitive troponin-I) were significantly low in the mDNC group (P = .0034). Myocardial biopsy results showed that myocardial PMNL accumulation was significantly high in the control group (P = .001). The amount of inotropic agent use was significantly high in the control group (P = .003). After weaning from ECC, the left ventricular stroke work index (LVSWI), cardiac index (CI), and heart rate (HR) were significantly high in the study group (P = .032; P = .002; P = .01). Postoperative blood and blood products requirements were significantly low in the mDNC group (P = .002). At pre-discharge echocardiography, the mDNC group demonstrated significantly higher ventricular ejection fraction (37.9 ± 4.3% and 29.7 ± 3.8%, respectively (P = .003).

Conclusion: Our study findings show that glutamate-aspartate supplemented del Nido cardioplegia significantly decrease myocardial PMNL accumulation with reduced release of biochemical markers, including cardiac troponin-I, TNF-alpha, and Pro-Bnp. Our study results demonstrated that amino acids supplementation in del Nido cardioplegia has some advantages in CABG patients, including the decrease of perioperative myocardial infarction and increase significantly the left ventricular functions including ventricular SVI and CI.

References

Arseni M. 1998. Potential Cardiovascular Applications of Glutamate, Aspartate, and Other. Amino Acids. Clin. Cardiol. 21,620-24.

Barner HB. 1991. Blood cardioplegia: a review and comparison with crystalloid cardioplegia. Ann Thorac Surg. 52:1354-67.

Bittle JA, Shine KI. 1983. Protection of ischemic rabbit myocardium by glutamic acid. Am J Physiol. 245:406-12.

Bolling KS, Halldorsson A, Allen BS, Rahman S, Wang T, Kronon M, Feinberg H. 1997. Prevention of the hypoxic reoxygenation injury with the use of a leukocyte-depleting filter. J Thorac Cardiovasc Surg. 113: 1081-90.

Breda MA, Drinkwater DC, Laks H, Bhuta S, Corna AF, Davtyan HG, Chang P. 1989. Prevention of reperfusion injury in the neonatal heart with leukocyte-depleted blood. J Thorac Cardiovasc Surg. 97: 654 -/65.

Buckberg GD, Beyersdorf F, Allen BS, Robertson JM. 1995. Integrated myocardial management: background and initial application. J Card Surg. 10:68-89.

Byrne JG, ppleyard RF, Lee CC, Couper GS, Scholl FG, Laurence RG, Cohn LH. 1992. Controlled reperfusion of the regionally ischemic myocardium with leukocyte-depleted blood reduces stunning, the no-reflow phenomenon, and infarct size. J Thorac Cardiovasc Surg. 103: 66-/72.

Carrier M, Pellerin M, Perrault LP, Bouchgard D, Page P, Searle N, et al. 2002. Cardioplegic arrest with L-taurin improves myocardial protection: results of a prospective randomized clinical trial. Ann Thorac Surg. 73:837-41.

Chambers DJ, Haire K, Morley N, Fairbanks L, Strumia E, Young CP, et al. 1996. St. Thomas’ Hospital cardioplegia: enhanced protection with exogenous creatine phosphate. Ann Thorac Surg. 61:67-75.

Chocron S, Alwan K, Toubin G, Clement F, Kaili D, Taberlet C, et al. 1996. Crystalloid cardioplegia route of delivery and cardiac troponin release. Ann Thorac Surg. 62:481-5.

Cohen G, Borger MA, Weisel RD, Rao V. 1999. Intraoperative myocardial protection: current trends and future perspective. Ann Thorac Surg. 68:1995-2001.

Datz FL, Seabold SL, Brown ML, et al. 1997. Society of Nuclear Medicine, Procedure guideline for technetium-99m exametazime (HMPAO) labeled leukocyte scintigraphy for suspected infection/inflammation. Journal of Nuclear Medicine. 38; 987-990.

De Vecci E, Paroni R, Pala MG, Di Credica G, Agape V, Gobbi C, Bonini PA, Paolini G, Grossi A. 1997. Role of leukocytes in free radical production during myocardial revascularization. Heart. 77: 449-/55.

Duman U, Dogan OF. 2006. Transient beneficial effects of glutamate-aspartate-enriched cardioplegia on ventricular functions in coronary artery bypass grafting. J Card Surg. 21(5):523-5.

Engler RL, Schmid-Schonbein GW, Pavelec RS. 1983. Leucocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol. 111:98.

Fiore AC, Swartz MT, Nevett R, Vieth PJ, Magrath RA, Sherrick A, Barner HP. 1998. Intermittent Antegrade Tepid Versus Cold Bloob Cardioplegia in Elective Myocardial Revascularization. Ann Thorac Surg. 65:1559–65.

Fukushima N, Shirakura R, Nakata S, Kaneko M, Miyagawa S, Naka Y, Chang JC, Matsumiya G, Nakano S, Matsuda H. 1994. Study of efficacies of leukocyte-depleted terminal blood cardioplegia in 24-hour preserved hearts. Ann Thorac Surg. 58: 1651-56.

Habazetl H, Martinek V, Vollmar B. 1997. Enhancement of the leukocyte-endothelial cell interaction in collecting venules of skeletal muscle by protamine. J Thorac Cardiovasc Surg. 113:784-91.

Hayashi Y, Sawa Y, Nishimura M, Ichikawa H, Kagisaki K, Ohtake S, Matsuda H. 2000. Clinical evaluation of leukocyte-depleted blood cardioplegia for pediatric open heart operation. Ann Thorac Surg. 69: 1914 -/19.

Hynninen M, Borger MA, Rao V, Weisel RD, Christakis GT, Carroll Cheng DC. 2001. The effect of insulin cardioplegia on atrial fibrillation after high risk coronary bypass surgery: a double-blinded, randomized controlled trial. Anesth Analg. 92:810-6.

Ichihara T, Yasuura K, Maseki T, Matsuura a, Miyahara K, Ito T, Kato S, Mizuno S, Tamaki S, Seki A. 1994. The effects of using a leukocyte removal filter during cold blood cardioplegia. Surg Today. 24:966-72.

Kronon MT, Allen BS, Rahman S, Wang T, Tayyab NA, Bolling KS, Ilbawi MN. 2000. Reducing postischemic reperfusion damage in neonates using a terminal warm substrate-enriched blood cardioplegic reperfusate. Ann Thorac Surg. 70:765-70.

Lewis M, Littlejohns B, Lin H, Angelini GD, Suleiman MS. 2014. Cardiac taurine and principal amino acids in right and left ventricles of patients with either aortic valve stenosis or coronary artery disease: the importance of diabetes and gender. SpringerPlus. 3:523.

Mallidi HR, Sever J, Tamariz M, Singh S, Hanayama N, Christakis GT, et al. 2003. The short-term and long-term effects of warm or tepid cardioplegia. J Thorac Cardiovasc Surg. 125:711-20.

Martin J, Benk C. Multimedia Manuel of Cardiothoracic Surgery. Blood Cardioplegia.

Martin J, Krause M, Benk C, et al. 2003. Blood Cardioplegia filtration Perfusion. 18:75-80.

Mehta JL, Nichols WW, Mehta P. 1983. Neutropils as potential participants in acute myocardial ischemic myocardial injury Am Heart J. 106:8-13.

Mizuno A, Baretti R, Buckberg GD. 1997. Endothelial stunning and myocyte recovery after reperfusion of jeopardized muscle. A role of L-Arginine blood cardioplegia. J Thorac Cardiopvasc Surg. 113:379-89.

Mullane K, Kraemer R, Smith B. 1985. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods.14:157-67.

Mullane KM, Read N, Salmon JA. 1984. Role of lucocytes in acute myocardial infarction in anesthetized dogs: Relationship to myocardial salvage by anti-inflammatory drugs J Pharmacol Exp Ther. 228:510-22.

Palatianos GM, Balentine G, Papadakis EG, Triantafillou CD, Vassili MI, Lidoriki A, Dinopoulos A, Astras GM. 2004. Neutrophil depletion reduces myocardial reperfusion morbidity Ann. Thorac. Surg. 77(3): 956-61.

Pisarenko OI. 1996. Mechanisms of myocardial protection by amino acids: facts and hypotheses. Clin Experimen Pharma & Physio. 23:627-33.

Ren G, Dewald O, Frangogiannis NG. 2003. Inflammatory mechanisms in myocardial infarction. Curr Drug Targets Inflamm Allergy 2: 242–256.

Roth M, Kraus B, Scheffold T, Reuthebuch O, Klo¨vekorn WP, Bauer EP. 2000. The effect of leukocyte-depleted blood cardioplegia in patients with severe left ventricular dysfunction: a randomized, double-blind study. J Thorac Cardiovasc Surg. 120: 642-50.

Rowe G, Manson N, Caplan M. 1983. Hydrogen peroxide and hydroxyl radical mediation of inactivated leucocyte depression of cardiac sarcoplasmic reticulum: Participation of the cyclooxigenase pathway. Circ Res. 53:584-91.

Sato H, Zhao ZQ, Jordan J. 1997. Basal nitric oxyde expresses endogenous cardio protection during reperfusion by inhibition of neutrophil mediated damage after surgical revascularization. J Thorac Cardiovasc Surg. 113:379-89.

Sawa Y, Matsuda H, Shimzaki Y, Kaneko M, Nishimura M, Amemiya A, Sakai K, Nakano S. 1994. Evaluation of leukocyte-depleted terminal blood cardioplegic solution in patients undergoing elective and emergency coronary artery bypass grafting. J Thorac Cardiovasc Surg. 108:1125-31.

Suzuki I, Ogoshi N, Chiba M, Komatsu T, Moizumi Y. 1998. Clinical evaluation of a leukocyte-depleting blood cardioplegia filter (BC1B) for elective open-heart surgery. Perfusion. 13: 205-10.

Tomoeda H. 1999. Effects of leukocyte-depleted warm blood cardioplegia on cardiac and endothelial function. Kurume Med J. 46: 31-38.

Uyar I, Mansuroğlu D, Kirali K, Erentuğ V, Bozbuğa NU, Uysal G, Yakut C. 2005. Aspartate and glutamate-enriched cardioplegia in left ventricular dysfunction. J Card Surg. 20(4):337-44.

Vinten-Johansen J, Yellon DM, Opie LH. 2005. Postconditioning: a simple, clinically applicable procedure to improve revascularization in acute myocardial infarction. Circulation 112: 2085–2088.

Wilson I, Gardner TJ, DiNatalle CM. 1993. Temporary leucocyte depletion reduces ventricular disfunction during prolonged postischemic reperfusion. J Thorac Cardiovasc Surg. 106:805-810.

Yazicioglu Y, Erdogan S. 2004. SPSS Uygulamalı Bilimsel Arastirma Yöntemleri. Detay Yayinlari, Detay Yayincilik, ISBN: 975-8326-98-8. Page 324.

Published

2021-01-15

How to Cite

Temizturk, Z., Azboy, D., & Uysal, A. (2021). The Effects of Amino Acids Enriched Del Nido Cardioplegia on Myocardial Leucocyte Accumulation and Ventricular Functions in Patients Undergoing Coronary Artery Bypass Grafting Surgery. The Heart Surgery Forum, 24(1), E038-E047. https://doi.org/10.1532/hsf.3265

Issue

Section

Articles